Doxepin-d 3

Overview

Doxepin -d 3 is the deuterium labeled Doxepin ( HY-B0725A ). Doxepin s an orally active tricyclic antidepressant agent. Doxepin is a potent and selective histamine receptor H1 antagonist. Doxepin is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2. Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant. Doxepin has therapeutic effects in atopic dermatitis, chronic urticarial, can improve cognitive processes, protect central nervous system. Doxepin has also been proposed as a protective factor against oxidative stress.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Others | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Others | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Cytochrome P450 | Products > Signaling Pathways > Histamine Receptor

Product Information

• Catalog No.: HY-139521S
• CAS No.: 138387-16-3
• Molecular Formula: C19H18D3NO
• Molecular Weight: 282.39
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source